What is OS Therapies's deferred tax assets, gross?

OS Therapies (OSTX) reported deferred tax assets, gross of $13.21M in Q4 2025.

What is the long-term trend for OS Therapies's deferred tax assets, gross?

Over 2 years (2023 to 2025), OS Therapies's deferred tax assets, gross has grown at a 42.8% compound annual growth rate (CAGR), from $6.48M to $13.21M.

OS Therapies OSTX Deferred Tax Assets, Gross

Deferred Tax Assets, Gross at other companies

Banner CorporationBANR

$127.77M-14.3%

Corebridge FinancialCRBG

$7.82B-13.6%

Bank of AmericaBAC

$24.18B-5.9%

Silvercrest Asset Management GroupSAMG

$1.71M-59.6%

Center BancorpCNOB

$137.68M+193%

MSCIMSCI

$191.15M+1.9%

Other financials

Income statement

See full

Operating income-$10.2M-103%

Net income-$10.4M-168%

EPS (diluted)-$0.27-50.0%

Balance sheet

See full

Cash & equivalents$917.6K-69.1%

Total debt$20.0M—

Total equity-$10.8M-159%

Total assets$7.3M+71.7%

Cash flow

See full

Operating cash flow-$4.6M-32.6%

CapEx$316.4K—

Free cash flow-$3.7M—

Valuation

See full

Market cap$84.62M+65.5%

Enterprise value$103.7M—

Returns & leverage

See full

Return on equity470%—

Debt / equity-1.8×—

Current ratio0.1×-1.1×

Where this comes from

Reported directly by OS Therapies in its filing.

Tagged under the XBRL concept us-gaap:DeferredTaxAssetsGross.

The official record: OS Therapies’s 10-K, filed March 31, 2026, on SEC EDGAR. View the filing →

Ask your AI about OS Therapies's deferred tax assets, gross.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is OS Therapies's deferred tax assets, gross?: OS Therapies (OSTX) reported deferred tax assets, gross of $13.21M in Q4 2025.
What is the long-term trend for OS Therapies's deferred tax assets, gross?: Over 2 years (2023 to 2025), OS Therapies's deferred tax assets, gross has grown at a 42.8% compound annual growth rate (CAGR), from $6.48M to $13.21M.